AbbVie
Generated by Meeveem AI
"A global pharmaceutical company discovering innovative medicines for 75+ serious conditions"
About AbbVie
AbbVie discovers and delivers medicines for complex health challenges. Its portfolio spans immunology, oncology, neuroscience and eye care, alongside products and services from Allergan Aesthetics. The company’s website reports treatments for more than 75 conditions, reaching around 60 million people annually in over 175 countries.
Founded in 2013 following its separation from Abbott, AbbVie is headquartered in North Chicago, Illinois. Its work combines drug discovery and clinical development with regulatory expertise and commercial operations. In the UK, teams work across the company’s therapeutic portfolio and pipeline, with offices in Maidenhead and Marlow and research capabilities in Oxford.
UK teams and research
AbbVie’s UK sites include a global centre of regulatory excellence, international aesthetics functions and a clinical development team. The company expanded its Oxford research facility in November 2026 as part of more than £120 million invested and committed to UK research, academic collaborations and talent development.
58000
Team Members
2013
Founded
Pharma
Sector
Hybrid
Work Environment